# Supreme Court preserves telehealth abortion access in ruling with ripples for Nebraska  
**Published:** 2026-05-15T00:53:40.000Z  
**Source:** [Nebraska Examiner](https://nebraskaexaminer.com/2026/05/14/repub/us-supreme-court-rules-telehealth-abortion-can-resume-while-lawsuit-continues/)  
**AI-generated:** yes (claude-haiku-4-5-20251001)  
**Canonical:** https://lincolne.news/article/supreme-court-preserves-telehealth-abortion-access-in-ruling-with-ripples-for

The U.S. Supreme Court ruled Thursday that [telehealth access to the abortion drug mifepristone can continue](https://stateline.org/2026/05/14/us-supreme-court-rules-telehealth-abortion-can-resume-while-lawsuit-continues/) while a federal appeals court considers the merits of a high-stakes lawsuit brought by Louisiana against the Food and Drug Administration.

The decision provides temporary reprieve for abortion access nationwide, though the outcome remains uncertain as the legal battle continues. Justices Samuel Alito and Clarence Thomas dissented, with Thomas arguing the telehealth rule violates the Comstock Act, a largely unenforced 1873 law.

The ruling comes as [Nebraska Attorney General Mike Hilgers led 23 states in supporting Louisiana's lawsuit](https://ago.nebraska.gov/us-fifth-circuit-court-appeals-panel-judges-blocks-access-through-mail-mifepristone-abortion-pill), arguing that the telehealth rule allows out-of-state doctors to circumvent Nebraska's restrictions on medication abortion. Nebraska law already bans telehealth access to mifepristone and requires in-person dispensing, making the national ruling less immediately consequential in the state.

Medication abortions using mifepristone account for nearly two-thirds of all U.S. abortions. The drug, approved by the FDA in 2000, has been available via telehealth since 2021, allowing patients to obtain pills through the mail without in-person doctor visits.

Dr. Camille A. Clare, president of the American College of Obstetricians and Gynecologists, called Thursday's decision a relief but warned that ongoing legal uncertainty harms patients. "The chaos and confusion wrought by competing decisions and the revocation and restoration of access on an almost daily basis do real harm to patients," she said.

Anti-abortion groups and state officials expressed disappointment. Jor-El Godsey, president of Heartbeat International, said women deserve better than abortion drugs sent through the mail.

The Supreme Court's temporary order came after the 5th Circuit Court of Appeals sided with Louisiana on May 1, ruling that mifepristone must be dispensed in person. The manufacturers of the drug sought emergency relief, leading the Supreme Court to issue a stay on May 4, extended through Thursday.

FDA Commissioner Marty Makary resigned Tuesday after months of criticism from anti-abortion groups who accused him of slow-walking a safety review of mifepristone. Anti-abortion groups have already begun pressuring Acting Commissioner Kyle Diamantas, with Live Action founder Lila Rose reporting he told her the abortion pill review is a top priority.

The lawsuit will continue in federal court while the Trump administration conducts its review. Access is expected to remain stable at least through next year unless the court rules otherwise.

## Sources

- [Nebraska Examiner](https://nebraskaexaminer.com/2026/05/14/repub/us-supreme-court-rules-telehealth-abortion-can-resume-while-lawsuit-continues/)
- [Stateline reporting on Supreme Court decision](https://stateline.org/2026/05/14/us-supreme-court-rules-telehealth-abortion-can-resume-while-lawsuit-continues/)
- [Nebraska Attorney General statement on 5th Circuit ruling](https://ago.nebraska.gov/us-fifth-circuit-court-appeals-panel-judges-blocks-access-through-mail-mifepristone-abortion-pill)

---

This article was generated by AI (claude-haiku-4-5-20251001) based on source material from Nebraska Examiner, enriched with 2 web searches. The original source is available at https://nebraskaexaminer.com/2026/05/14/repub/us-supreme-court-rules-telehealth-abortion-can-resume-while-lawsuit-continues/.